LOADING ...

Luyện nghe bài hát Rttel Mich

  1. Home
  2. Music
  3. Ca sỹ T
  4. Toxoplasma

Hướng dẫn luyện nghe

Bạn hãy nghe bài hát và điền từ còn thiếu vào các ô trống.
Sau khi điền hết, bạn nhấn nút gửi bài ở phía dưới để được chấm điểm.
Với những câu trả lời sai, bạn hãy rê chuột lên ô nhập để xem đáp án đúng.
Nếu bạn muốn luyện nghe lại với các ô trống khác thì click vào link "Làm lại bài điền từ khác" ở cuối bài.

Bắt đầu làm bài nào

Mach zum Objekt
Ich dir den Hengst
mit mir die Sau
Und was du noch denkst
Schei auf die
Sie macht uns nur
dir deine Seele raus
Von ab bist du Punk

Rttel schttel mich
mich auf dem Kchentisch
Rttel mich mich
kommt es ber mich
Rttel mich schttel
Fick auf dem Kchentisch
Rttel mich schttel
Tag denk ich an dich
Erzhl mir von Unschuld
Von Liebe so
wird mir schlecht
Wo ist das Klo
Oder bist du Nonne
reich mir das Klistier
Falte Hnde
Und gr den von mir

Videos

REPAIRING A TOXOPLASMOSIS RELATED RETINAL DETACHMENT WITH EXTERNAL NEEDLE DRAINAGE
REPAIRING A TOXOPLASMOSIS RELATED RETINAL DETACHMENT WITH EXTERNAL NEEDLE DRAINAGE
Targeted therapy for the treatment of follicular lymphoma
Targeted therapy for the treatment of follicular lymphoma
Tazemetostat and rituximab in r/r follicular lymphoma
Tazemetostat and rituximab in r/r follicular lymphoma
T Cell Therapies | Adriana Rossi, MD | TANDEM 2022
T Cell Therapies | Adriana Rossi, MD | TANDEM 2022
Die Behandlung des Multiplen Myeloms (mit russischen Untertiteln)
Die Behandlung des Multiplen Myeloms (mit russischen Untertiteln)
Perspectives on the treatment of patients with R/R multiple myeloma
Perspectives on the treatment of patients with R/R multiple myeloma
Advances in CAR-T therapy for R/R multiple myeloma: ide-cel & cilta-cel
Advances in CAR-T therapy for R/R multiple myeloma: ide-cel & cilta-cel
Phase I trial of plamotamab in r/r NHL
Phase I trial of plamotamab in r/r NHL
HRQoL and frail patients with R/R multiple myeloma
HRQoL and frail patients with R/R multiple myeloma
Multiple myeloma and COVID-19 in the Czech Republic
Multiple myeloma and COVID-19 in the Czech Republic
T-cell redirecting therapies for R/R multiple myeloma
T-cell redirecting therapies for R/R multiple myeloma
Teclistamab in relapsed/refractory multiple myeloma
Teclistamab in relapsed/refractory multiple myeloma
Long-term follow-up of postauto cell transplantation strategies in the upfront treatment of MM
Long-term follow-up of postauto cell transplantation strategies in the upfront treatment of MM
Dr. Raje on the Rationale for CAR T-Cell Therapy in Multiple Myeloma
Dr. Raje on the Rationale for CAR T-Cell Therapy in Multiple Myeloma
CARTITUDE-5: VRd + cilta-cel or Rd in newly diagnosed multiple myeloma
CARTITUDE-5: VRd + cilta-cel or Rd in newly diagnosed multiple myeloma
Talquetamab + Daratumumab Is Well Tolerated in Relapsed/Refractory Multiple Myeloma Patients
Talquetamab + Daratumumab Is Well Tolerated in Relapsed/Refractory Multiple Myeloma Patients
Update on Phase I trial of teclistamab in R/R myeloma
Update on Phase I trial of teclistamab in R/R myeloma
Up-and-coming therapies: talquetamab & cevostamab
Up-and-coming therapies: talquetamab & cevostamab
Real-world data on outcomes of t(11;14) multiple myeloma
Real-world data on outcomes of t(11;14) multiple myeloma
Phase I trial of a FcRH5-targeted BiTE in R/R myeloma
Phase I trial of a FcRH5-targeted BiTE in R/R myeloma